In acute myeloid leukemia (AML), abnormal expression of PTK2 is associated with poor prognosis and treatment resistance (18); therefore, exploring the role of PTK2 in APL is of great significance for understanding the relationship between lipid metabolism disorders and APL. The gene discussed is PTK2; the disease is Disorder of lipid metabolism.